In response to earlier studies linking decreased 5-HT neurotransmission and/or 5-HT receptor dysfunction to PE, Janssen et al. investigated polymorphisms of the 5-HT transporter-linked promoter ...

Neushen Therapeutics Inc. has synthesized 5-HT2A receptor agonists reported to be useful for the treatment of depression, schizophrenia, anxiety and post-traumatic stress disorder.

However, this work concentrated on only one serotonin receptor, the 5-HT 4 receptor. The researchers began by scanning the ...

Detailed price information for Bright Minds Biosciences Inc (DRUG-Q) from The Globe and Mail including charting and trades.